Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

被引：0
|
作者：
Evelina Miele
Gian Paolo Spinelli
Federica Tomao
Angelo Zullo
Filippo De Marinis
Giulia Pasciuti
Luigi Rossi
Federica Zoratto
Silverio Tomao
机构：
[1] Department of Experimental Medicine University of Rome "Sapienza" viale Regina Elena 324,Operative Unit of Medical Oncology, S. Maria Goretti Hospital
[2] University of Rome "Sapienza" – Latina-via Canova,Gastroenterology and Digestive Endoscopy
[3] "Nuovo Regina Margherita" Hospital,Thoracic Oncology Unit I, Department of Lung Diseases
[4] San Camillo and Forlanini Hospitals,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 27卷
关键词：
Positron Emission Tomography; Small Cell Lung Cancer; Mediastinal Lymph Node; Mediastinal Lymph Node Metastasis; Positron Emission Tomography Examination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
PET (Positron Emission Tomography) is a nuclear medicine imaging method, frequently used in oncology during the last years. It is a non-invasive technique that provides quantitative in vivo assessment of physiological and biological phenomena. PET has found its application in common practice for the management of various cancers.
引用
收藏
相关论文
共 50 条
  • [41] Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT for T and N staging in patients with non-small-cell lung cancer
    Eric Laffon
    Roger Marthan
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 522 - 523
  • [42] Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT for T and N staging in patients with non-small-cell lung cancer
    Laffon, Eric
    Marthan, Roger
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (02) : 522 - 523
  • [43] Is F-18 fluoro-2-deoxy-D-glucose Positron Emission Tomography (FDG-PET/CT) of Value in Soft Tissue Sarcoma Management?
    Orr, W. S.
    Watson, K.
    Feig, R.
    Ikoma, N.
    De Rosa, N.
    Giacco, G.
    Ravi, V.
    Benjamin, R. S.
    Madewell, J. E.
    Cormier, J. N.
    Hunt, K. K.
    Roland, C. L.
    Feig, B. W.
    Torres, K.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S147 - S147
  • [44] Differential Uptake of F18-fluoro-deoxy-glucose (FDG) and F18-fluoro-deoxy-l-thymidine (FLT) Detected by Serial PET/CT Imaging During Radical Chemoradiation for Non-small Cell Lung Cancer (NSCLC).
    Ball, D.
    Everitt, S.
    Hicks, R.
    Callahan, J.
    Plumridge, N.
    Collins, M.
    Herschtal, A.
    Binns, D.
    Kron, T.
    Mac Manus, M.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S238 - S238
  • [45] Prognostic value of metabolic parameters measured by 18F-Flurodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in surgically resected non small cell lung cancer (NSCLC) patients
    Mathew, B.
    Purandare, N.
    Shah, S.
    Agarwal, A.
    Puranik, A.
    Rangarajan, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S499 - S499
  • [46] The role of 2-18F-fluoro-2-deoxy-d-glucose positron emission tomography (F18-FDG-PET) in the diagnosis of giant cell arteriitis of the temporal arteries
    Brodmann, M
    Passath, A
    Lipp, RW
    Stark, G
    Pabst, E
    Seinost, G
    Pilger, E
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 213 - 213
  • [47] The role of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer
    Umesaki, N
    Tanaka, T
    Miyama, M
    Kawabe, J
    Okamura, T
    Koyama, K
    Ochi, H
    Ogita, S
    ONCOLOGY REPORTS, 2000, 7 (06) : 1261 - 1264
  • [48] Clinical impact of 18F-FDG PET on the management of patients with early non-small-cell lung cancer by conventional workup
    Yen, R.
    Yu, C.
    Lee, Y.
    Chang, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S331 - S331
  • [49] Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer
    de Groot, JWB
    Links, TP
    Jager, PL
    Kahraman, T
    Plukker, JTM
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (08) : 786 - 794
  • [50] Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid Cancer
    J. W. B. de Groot
    Th. P. Links
    P. L. Jager
    T. Kahraman
    J. Th. M. Plukker
    Annals of Surgical Oncology, 2004, 11 : 786 - 794
12345